Advanced Filters
noise
Found 649 clinical trials
A Alicia Patrick

WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment

The purpose of this study is to evaluate the feasibility of using a commercial WATD (Wearable Activity Tracker Device) to collect HRV (Heart Rate Variability) data from pancreatic and breast cancer patients.

18 years of age All Phase N/A
J Jihui Hao, MD

The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer

This study aimed to evaluate the impact of adjuvant chemotherapy on survival in patients with Stage I pancreatic cancer stratified by pathologic risk factors.

18 years of age All Phase N/A
E Eleni Arnaoutoglou, MD, PhD

Venous Thromboembolism in Primary Pancreatic Tumour Resection

This study will evaluate the development of venous thromboembolism (VTE) and possible determinants in patients with primary pancreatic cancer undergoing pancreatic cancer resection.

18 years of age All Phase N/A
c chunfu zhu, phD

In This Study, a Retrospective Analysis Was Conducted to Explore the Risk Factors for Patients Undergoing Pancreaticoduodenal Surgery (PD) to Achieve TO, and a Nomogram Prediction Model Was Further Established to Promote the Standardization and Standardization of PD Surgical Quality Evaluation.

This study is committed TO exploring the risk factors affecting patients receiving pancreaticoduodenal surgery (PD) to achieve TO by retrospective analysis of clinical data of patients receiving PD surgery in Changzhou Second People Hospital from January 2016 to December 2024, and further establishing a nomogram prediction model. In order to …

40 - 85 years of age All Phase N/A
D Daniel J Renouf, MD

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

Researchers are looking for better ways of understanding and treating pancreatic cancer. The purpose of this study is to see how useful it is to look for changes and characteristics in your genes (molecules that contain instructions for the development and functioning of the cells) and the genes within the …

18 years of age All Phase N/A
B Bianca Verboski

Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)

This study is being conducted to better understand how pancreatic cancer behaves during treatment and how we can improve methods for monitoring disease progression. The research aims to determine whether small molecules present in the blood, called miRNAs, can help doctors assess whether the treatment is working or needs adjustment. …

18 years of age All Phase N/A
T Tuo Dr. Li, Vice Professor

Pancreatic Cancer and Diabetes Mellitus

The goal of this observational study is to learn about post-surgery of pancreatic cancer diabetes mellitus.The main questions it aims to answer are: Are the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) after pancreatic cancer of different etiologies the same? Are alterations in endocrine and exdocrine secretory …

18 years of age All Phase N/A
C Colette N Ngo Ndjom, MS

Evaluation of Resection Techniques for Pancreatic Tumors

The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital …

18 years of age All Phase N/A
O Oskar Franklin, PhD

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer

18 years of age All Phase N/A
P Philippe AH-SOUNE, MD

Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency

The purpose of the study is to evaluate the oncological efficacy of pancreatic radiofrequency by the objective response rate (complete and partial responses according to RECIST 1.1.), 5 years after the end of treatment.

18 years of age All Phase N/A

Simplify language using AI